Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment ...Middle East

News by : (Medscape) -
Patients treated with upadacitinib have lower rates of lung function decline with no significant adverse events. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment )

Also on site :

Most Viewed News
جديد الاخبار